Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis

BACKGROUND: Atrial fibrillation (AF) increases risk of stroke, and although this stroke risk can be ameliorated by warfarin therapy, some patients decline to adhere to warfarin therapy. A prospective clinical study could be conducted to determine whether knowledge of genetic risk for AF could increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiffman, Dov, Perez, Marco V., Bare, Lance A., Louie, Judy Z., Arellano, Andre R., Devlin, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587718/
https://www.ncbi.nlm.nih.gov/pubmed/26419225
http://dx.doi.org/10.1186/s12872-015-0100-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587718/
https://www.ncbi.nlm.nih.gov/pubmed/26419225
http://dx.doi.org/10.1186/s12872-015-0100-7

Ejemplares similares